Skip to main content

Advertisement

Table 5 Gastrointestinal Symptom Rating Scale Total Score

From: A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms

Visit Gas Defense Placebo
Day 0 Screen/Rand 40.8 ± 19.8 (29) 39.4 ± 12.1 (29)
Day 14 Mid-Study 29.0 ± 8.7 (29) 31.6 ± 11.4 (29)
Day 29 End-of-Study 25.2 ± 10.0 (29) 29.4 ± 9.7 (29)
Change from Day 0 to Day 14 -11.9 ± 16.4 (29) -7.8 ± 11.7 (29)
Change from Day 0 to Day 29 -15.6 ± 17.4 (29) -9.9 ± 12.3 (29)
  1. Values are expressed as mean ± standard deviation.